This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Disorders related to length of gestation and fetal growth
P16_DISORD_RELATED_LENGTH_GESTATION_FETAL_GROWTH
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
991 |
4. Check minimum number of eventsNone |
991 |
5. Include endpoints |
991 |
6. Filter based on genotype QC (FinnGen only) |
991 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P
- Name in latin
- Perturbationes ad longitudinem gestationis et crescendum fetus pertinentes
Disorders related to length of gestation and fetal growth
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 991 | 578 | 413 |
| Unadjusted period prevalence (%) | 0.19 | 0.20 | 0.18 |
| Median age at first event (years) | 0.00 | 0.00 | 0.00 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 853
- Matched controls
- 8108
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P07.3
ICD-10 Finland
Other preterm infants
+∞
323.0
587
*
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
34.1
251.5
341
155
P07.12
ICD-10 Finland
Other low birth weight 2000-2499 g
+∞
139.0
132
*
P59.0
ICD-10 Finland
Neonatal jaundice associated with preterm delivery
140.2
138.3
147
12
P05.1
ICD-10 Finland
Small for gestational age
+∞
121.7
116
*
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
224.5
100.9
104
5
P07.11
ICD-10 Finland
Other low birth weight 1500-1999 g
+∞
87.4
84
*
P05.0
ICD-10 Finland
Light for gestational age
+∞
79.0
76
*
P01.5
ICD-10 Finland
Fetus and newborn affected by multiple pregnancy
137.5
73.7
79
6
P07.1
ICD-10 Finland
Other low birth weight
+∞
68.4
66
*
P70.4
ICD-10 Finland
Other neonatal hypoglycaemia
13.5
65.1
118
95
P07.2
ICD-10 Finland
Extreme immaturity
+∞
64.2
62
*
602
Kela drug reimbursment
Children's severe malnutrition
9.2
58.3
129
153
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
175.0
49.4
52
*
P00.0
ICD-10 Finland
Fetus and newborn affected by maternal hypertensive disorders
28.6
42.9
59
21
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
6.3
42.0
119
202
WX722
NOMESCO Finland
PEEP
10.1
41.1
85
88
P07.10
ICD-10 Finland
Other low birth weight 1000-1499 g
+∞
40.2
39
*
P08.0
ICD-10 Finland
Exceptionally large baby
+∞
39.1
38
*
P08.1
ICD-10 Finland
Other heavy for gestational age infants
+∞
37.1
36
*
Z38.3
ICD-10 Finland
Twin, born in hospital
62.8
32.5
38
6
H35.1
ICD-10 Finland
Retinopathy of prematurity
307.8
30.4
31
*
P29.30
ICD-10 Finland
Delayed closure of the ductus arteriosus
39.6
28.5
36
9
P70.1
ICD-10 Finland
Syndrome of infant of a diabetic mother
19.5
28.1
43
22
P22.1
ICD-10 Finland
Transient tachypnoea of newborn
6.8
27.3
71
106
R4110
NOMESCO Finland
Physiotherapy
2.5
25.6
251
1160
WX882
NOMESCO Finland
High dependency care
3.2
24.5
146
498
P07.02
ICD-10 Finland
Extremely low birth weight 750-999 g
+∞
21.5
21
*
E34.31
ICD-10 Finland
Short stature, prenatal disorder
11.7
21.4
40
34
Z3229
NOMESCO Finland
Other healthcare associate professional
2.9
20.3
138
509
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.3
19.4
202
946
J45.1
ICD-10 Finland
Nonallergic asthma
2.8
19.0
138
529
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
18.5
136
526
P01.10
ICD-10 Finland
Fetus and newborn affected by premature rupture of membranes 1-7 days before delivery
11.1
18.5
35
31
Z3226
NOMESCO Finland
Physiotherapist
2.2
18.1
235
1216
JAB00
NOMESCO Finland
Division and ligature of inguinal hernia sac
5.0
17.9
59
119
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.4
17.8
179
819
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
17.5
321
1904
P07.01
ICD-10 Finland
Extremely low birth weight 500-749 g
+∞
17.4
17
*
F82
ICD-10 Finland
Specific developmental disorder of motor function
4.1
17.4
70
173
Z2446
NOMESCO Finland
Social worker
2.3
17.3
193
929
RK312
NOMESCO Finland
NA
19.5
17.3
26
13
P22.9
ICD-10 Finland
Respiratory distress of newborn, unspecified
7.9
17.0
39
49
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
16.7
259
1432
XG413
NOMESCO Finland
Spirometry with oscillometry
5.0
16.7
55
111
R62.0
ICD-10 Finland
Delayed milestone
3.2
16.6
93
301
P07.0
ICD-10 Finland
Extremely low birth weight
+∞
16.4
16
*
A11JC
ATC
Vitamins, other combinations
34.0
16.3
21
6
WW805
NOMESCO Finland
Transfer from treating institution to lower-Level care, accompanied by paramedic/nurse
26.8
16.1
22
8
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
16.1
281
1625
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
9.0
15.7
33
36
FDE00
NOMESCO Finland
Closure of patent ductus arteriosus
154.7
15.2
16
*
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
3.9
14.7
62
160
P22.8
ICD-10 Finland
Other respiratory distress of newborn
13.5
14.6
25
18
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
14.5
148
678
RK520
NOMESCO Finland
NA
24.3
14.3
20
8
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.7
14.0
100
378
WX730
NOMESCO Finland
Conventional respirator
7.4
13.9
33
44
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.0
12.9
190
1015
Z3231
NOMESCO Finland
Registered nurse
1.7
12.3
320
2077
P08.2
ICD-10 Finland
Post-term infant, not heavy for gestational age
+∞
12.3
12
*
Z2221
NOMESCO Finland
Medical doctor
1.9
12.3
220
1265
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
12.0
225
1311
ZXE00
NOMESCO Finland
One hour or less
1.7
11.8
335
2223
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
17.4
11.7
18
10
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
11.6
177
958
WX732
NOMESCO Finland
High frequency respirator
115.5
11.2
12
*
XA800
NOMESCO Finland
Neuropsychological investigation
2.4
10.9
96
408
6BB16
NOMESCO Finland
NA
24.1
10.9
15
6
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.0
10.8
157
830
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
7.2
10.6
25
34
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
10.5
224
1354
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
10.2
10.4
20
19
P52.0
ICD-10 Finland
Intraventricular (nontraumatic) haemorrhage, grade 1, of fetus and newborn
57.7
10.4
12
*
P03.4
ICD-10 Finland
Fetus and newborn affected by caesarean delivery
12.4
10.3
18
14
137
Kela drug reimbursment
Uraemia requiring dialysis
7.7
10.2
23
29
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
8.9
10.2
21
23
K40.2
ICD-10 Finland
Bilateral inguinal hernia, without obstruction or gangrene
15.5
10.1
16
10
P70.0
ICD-10 Finland
Syndrome of infant of mother with gestational diabetes
5.0
9.9
31
61
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
2.8
9.9
62
218
P21.1
ICD-10 Finland
Mild and moderate birth asphyxia
6.4
9.8
25
38
Z94.0
ICD-10 Finland
Kidney transplant status
5.2
9.7
29
54
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
9.6
146
783
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
9.5
212
1293
J21.9
ICD-10 Finland
Acute bronchiolitis, unspecified
2.2
9.5
96
435
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
9.4
98
452
R03AC02
ATC
salbutamol; inhalant
1.6
9.4
436
3235
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
2.1
9.3
104
494
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.2
9.3
28
53
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.6
9.1
299
2033
RT150
NOMESCO Finland
NA
4.1
9.0
34
81
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
4.7
8.9
29
60
KAC00
NOMESCO Finland
Nephrectomy
6.8
8.7
21
30
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.4
8.7
25
45
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
8.7
144
795
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
3.8
8.6
35
90
RS220
NOMESCO Finland
NA
3.7
8.6
36
95
A11CC03
ATC
alfacalcidol; systemic
4.2
8.5
31
72
P52.2
ICD-10 Finland
Intraventricular (nontraumatic) haemorrhage, grade 3, and grade 4 of fetus and newborn
48.0
8.5
10
*
Z00.6
ICD-10 Finland
Examination for normal comparison and control in clinical research programme
9.1
8.5
17
18
ZXA10
NOMESCO Finland
Bilateral
1.8
8.3
148
837
P28.4
ICD-10 Finland
Other apnoea of newborn
19.2
8.3
12
6
N04.80
ICD-10 Finland
Congenital nephrotic syndrome of the Finnish type
8.6
8.2
17
19
P61.2
ICD-10 Finland
Anaemia of prematurity
+∞
8.2
8
*
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
8.1
162
951
ZXD05
NOMESCO Finland
Urgent procedure
1.7
8.1
180
1093
Z99.2
ICD-10 Finland
Dependence on renal dialysis
7.8
7.8
17
21
ZX114
NOMESCO Finland
Intramuscular
4.0
7.8
30
74
R03BA02
ATC
budesonide; inhalant
1.8
7.8
142
811
P59.9
ICD-10 Finland
Neonatal jaundice, unspecified
2.9
7.7
45
152
B03XA01
ATC
erythropoietin; parenteral
6.3
7.6
19
29
UDC00
NOMESCO Finland
Ear microscopy
2.1
7.6
90
439
J21.90
ICD-10 Finland
Acute obstructive bronchitis in children
2.3
7.5
70
307
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.1
7.5
85
403
H66.9
ICD-10 Finland
Otitis media, unspecified
1.6
7.5
236
1570
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
7.5
126
698
R03BA05
ATC
fluticasone; inhalant
1.6
7.5
210
1357
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.1
7.4
82
387
P21.0
ICD-10 Finland
Severe birth asphyxia
7.1
7.4
17
23
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
5.7
7.4
20
34
A03FA02
ATC
cisapride; oral, rectal
3.0
7.3
40
130
Z2445
NOMESCO Finland
Psychologist
1.8
7.3
125
699
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
2.9
7.3
42
141
P77
ICD-10 Finland
Necrotizing enterocolitis of fetus and newborn
76.7
7.3
8
*
P36.3
ICD-10 Finland
Sepsis of newborn due to other and unspecified staphylococci
76.7
7.3
8
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.4
7.2
62
260
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
1.9
7.2
101
523
H50.31
ICD-10 Finland
Intermittent exotropia
3.0
7.2
39
126
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
1.7
7.2
168
1032
H53.0
ICD-10 Finland
Amblyopia ex anopsia
2.9
7.2
42
143
127
Kela drug reimbursment
Transplant complication
3.5
7.1
31
86
P02.1
ICD-10 Finland
Fetus and newborn affected by other forms of placental separation and haemorrhage
15.1
7.0
11
7
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.0
7.0
86
425
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
7.0
86
426
7AA02
NOMESCO Finland
NA
28.8
7.0
9
*
C08CA01
ATC
amlodipine; oral
3.2
6.9
34
103
B05DA
ATC
Isotonic solutions
7.0
6.9
16
22
RK310
NOMESCO Finland
NA
7.0
6.9
16
22
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.3
6.9
33
98
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
11.5
6.9
12
10
RL140
NOMESCO Finland
NA
3.5
6.8
30
84
EMB30
NOMESCO Finland
Adenotomy
1.6
6.7
185
1186
P00.8
ICD-10 Finland
Fetus and newborn affected by other maternal conditions
13.2
6.7
11
8
FM2CE
NOMESCO Finland
NA
2.0
6.7
85
426
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.0
6.6
81
399
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
6.6
63
279
WW500
NOMESCO Finland
Blood transfusion
2.8
6.6
39
134
WX725
NOMESCO Finland
Noninvasive ventilation
3.6
6.6
28
76
Z49.1
ICD-10 Finland
Extracorporeal dialysis
7.9
6.6
14
17
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
6.5
126
732
A12AA04
ATC
calcium carbonate; oral
5.1
6.5
19
36
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
6.9
6.5
15
21
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
6.4
102
556
UGC02
NOMESCO Finland
Rigid bronchoscopy
4.1
6.4
23
54
RK410
NOMESCO Finland
NA
11.7
6.4
11
9
TJF80
NOMESCO Finland
Ostomy education
4.7
6.4
20
41
ZX106
NOMESCO Finland
Intranasal
9.6
6.3
12
12
TJD20
NOMESCO Finland
Change of gastrostomy tube
4.1
6.3
23
55
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
2.2
6.3
63
286
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
2.3
6.3
54
230
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.8
6.2
102
559
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
5.9
6.2
16
26
H01AC01
ATC
somatropin; parenteral
2.6
6.2
43
161
P01.11
ICD-10 Finland
Fetus and newborn affected by premature rupture of membranes more than 7 days before delivery
+∞
6.1
6
*
Z49.2
ICD-10 Finland
Other dialysis
6.3
6.1
15
23
XKC03
NOMESCO Finland
Water cystometry
4.7
6.1
19
39
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
3.5
6.0
26
72
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
30
54
5.43
15.06
8.3
8.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
31
64
4.74
13.37
6.7
6.4
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
31
64
4.74
13.37
7.3
6.5
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
30
72
4.07
10.76
11.8
9.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
208
1348
1.60
7.69
20.1
9.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
232
1543
1.57
7.68
20.7
9.2
mmol/l
0.8
0.8
0.06
171
1105
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
232
1547
1.56
7.58
20.9
9.2
kpa
5.1
5.0
1.93
225
1496
(3009343) pH of Capillary blood
232
1547
1.56
7.58
20.8
9.2
ph
7.4
7.4
2.68
15
55
(3028626) Oxygen [Partial pressure] in Capillary blood
214
1412
1.57
7.30
20.2
9.1
kpa
9.6
9.7
0.50
206
1365
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
54
231
2.30
7.22
15.0
11.6
u/ml
82.7
295.6
1.57
12
26
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
58
259
2.21
7.01
12.7
10.1
iu/ml
806.9
350.0
—
8
35
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
137
827
1.67
6.68
5.0
3.2
%
21.9
21.9
0.01
131
782
(40768446) Kidney Pathology biopsy report
26
81
3.12
6.44
3.0
2.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
218
1485
1.51
6.35
16.8
10.9
mmol/l
1.4
1.3
2.52
212
1423
(3044640) Blood type and Crossmatch panel - Blood
241
1680
1.49
6.27
3.5
3.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
210
1423
1.52
6.26
3.3
3.5
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
12
21
5.50
6.19
1.2
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
58
275
2.07
6.06
1.8
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
58
275
2.07
6.06
1.8
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
38
153
2.42
5.85
4.9
4.4
umol/l
24.2
24.0
0.03
38
153
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
24
76
3.06
5.80
6.0
9.0
mg/l
2.4
2.3
0.10
19
60
(3004789) Transferrin [Mass/volume] in Serum or Plasma
141
891
1.59
5.71
4.8
3.1
g/l
2.6
2.6
0.09
136
848
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
46
204
2.21
5.70
2.0
1.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
55
265
2.04
5.53
2.5
2.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
55
265
2.04
5.53
2.4
2.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
142
910
1.57
5.41
1.5
1.4
u/ml
242.5
356.9
0.54
126
860
(3012095) Magnesium [Moles/volume] in Serum or Plasma
149
972
1.54
5.25
16.0
12.7
mmol/l
0.8
0.8
0.63
143
938
(3020779) Urea [Moles/volume] in Serum or Plasma
145
941
1.55
5.23
21.1
13.5
mmol/l
5.7
5.1
1.43
140
925
(40767503) Oxygen content in Capillary blood by calculation
32
127
2.45
5.11
3.4
3.3
%
17.8
17.8
0.02
24
78
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
45
208
2.11
5.06
1.9
2.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
99
592
1.66
5.00
12.6
8.1
ng/l
51.6
51.8
0.02
99
579
(3022948) Iron [Moles/volume] in Serum or Plasma
151
1003
1.51
4.89
4.8
3.0
umol/l
13.7
14.1
0.22
143
967
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
391
3085
1.35
4.76
23.4
12.5
mmol/l
1.2
1.2
0.46
372
2954
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
8
7
10.97
4.65
8.6
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
214
1540
1.42
4.57
3.8
2.8
mmol/l
2.4
2.4
0.10
200
1410
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
405
3229
1.33
4.54
22.8
11.4
mmol/l
1.2
1.2
0.19
373
2994
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
17
52
3.15
4.38
2.1
1.8
mg/l
0.7
1.3
1.41
17
46
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
17
52
3.15
4.38
2.1
1.8
mg/l
2.0
5.8
2.24
17
42
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
17
52
3.15
4.38
2.1
1.8
mg/l
2.8
3.6
0.37
11
40
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
17
52
3.15
4.38
2.1
1.8
mg/l
2.3
1.5
0.22
17
43
(3024891) Influenza virus A+B Ag [Presence] in Specimen
70
397
1.73
4.32
1.6
1.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
25
97
2.49
4.22
4.1
5.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
34
152
2.17
4.19
2.4
1.8
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
113
735
1.53
4.04
23.3
19.1
mg/l
1.1
1.0
1.76
113
723
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
7
7
9.59
3.89
1.9
3.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
34
157
2.10
3.89
9.6
7.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
50
265
1.84
3.88
17.2
9.2
mmol/l
23.2
23.0
0.21
50
248
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
16
51
3.02
3.88
2.2
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
37
177
2.03
3.86
2.0
1.6
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
17
57
2.88
3.79
1.9
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
161
1140
1.41
3.74
4.3
4.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
39
193
1.96
3.72
1.9
1.9
—
—
—
0
0
(3022670) pH of Venous cord blood
17
59
2.78
3.57
1.0
1.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
69
414
1.63
3.50
9.2
7.8
g/l
0.5
0.4
0.05
55
321
(40758558) Short blood count panel - Blood
307
2427
1.30
3.45
9.3
8.8
—
—
—
0
0
(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid
6
6
9.58
3.39
7.2
5.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
224
2628
0.76
3.30
2.4
2.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
129
898
1.43
3.29
2.7
2.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
190
1419
1.34
3.17
14.8
11.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
32
157
1.97
3.16
9.1
5.2
—
—
—
0
0
(44790048)
40
212
1.83
3.15
2.8
2.1
—
—
—
0
0
(44806118)
40
212
1.83
3.15
2.8
2.1
—
—
—
0
0
(44790049)
40
212
1.83
3.15
2.8
2.1
—
—
—
0
0
(44790047)
40
212
1.83
3.15
2.8
2.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
148
1064
1.38
3.14
2.9
4.8
mg/l
2.5
1.7
0.58
99
707
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
31
151
1.99
3.13
5.5
5.4
ug/l
2.4
2.2
0.19
31
151
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
451
3777
1.26
3.09
7.1
5.5
u/l
136.1
116.7
3.45
434
3539
(3018677) aPTT in Platelet poor plasma by Coagulation assay
149
1076
1.38
3.08
4.0
7.0
s
31.3
31.3
0.02
149
1065
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
7
11
6.10
3.07
1.4
3.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
429
3577
1.26
3.04
11.2
7.2
mmol/l
5.9
5.9
0.02
403
3336
(40761511) CBC panel - Blood by Automated count
805
7240
1.34
3.02
11.4
7.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
193
1460
1.32
2.95
6.0
3.4
e6/l
6.4
7.1
0.31
164
1282
(3023520) Reticulocytes [#/volume] in Blood
100
679
1.45
2.93
3.6
5.1
e9/l
66.0
64.6
0.09
74
420
(42870588) Differential panel, method unspecified - Blood
393
3258
1.25
2.89
9.8
9.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
27
129
2.02
2.89
3.3
2.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
190
1441
1.32
2.85
12.5
9.6
mmol/l
23.8
23.7
0.39
184
1408
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
26
124
2.03
2.80
1.6
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
30
152
1.91
2.74
6.8
6.0
u/ml
58.1
16.2
0.65
30
140
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
11
35
3.02
2.70
1.8
4.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
285
2292
1.26
2.70
8.0
7.9
umol/l
32.2
21.0
2.60
261
2083
(40757494) Bilirubin.total [Moles/volume] in Blood
16
63
2.44
2.69
10.4
3.0
umol/l
128.4
154.0
—
10
28
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
80
530
1.48
2.67
3.9
8.3
g/l
2.8
2.8
0.04
74
522
(3035637) Corticotropin [Mass/volume] in Plasma
52
313
1.62
2.66
2.0
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
98
676
1.42
2.66
2.6
1.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
26
127
1.98
2.64
9.8
6.9
mmol/l
1.2
1.6
0.39
16
61
(3021589) Normoblasts [#/volume] in Blood
473
4033
1.23
2.60
11.4
10.6
e9/l
0.0
0.0
0.76
388
3118
(3009214) Lutropin [Units/volume] in Serum or Plasma
92
630
1.43
2.60
2.3
2.2
u/l
5.8
5.8
0.02
65
413
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
98
679
1.42
2.60
2.7
2.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
140
1702
0.75
2.59
2.0
2.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
118
1468
0.73
2.55
1.8
2.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
40
229
1.69
2.49
3.5
3.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
37
209
1.71
2.42
1.5
2.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
22
105
2.02
2.39
4.2
4.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
173
1327
1.29
2.38
5.9
3.8
ph
7.4
7.4
0.31
38
219
(3051611) Lipemic interference index of Serum or Plasma
24
119
1.95
2.36
4.1
4.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
219
2477
0.80
2.28
2.3
2.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
291
2389
1.23
2.24
4.5
4.3
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
10
34
2.82
2.22
1.4
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
46
2.50
2.15
1.8
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
46
2.50
2.15
1.8
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
46
2.50
2.15
1.8
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
198
1565
1.26
2.14
15.5
10.0
mmol/l
1.1
1.1
0.13
165
1242
(3021960) Folate [Moles/volume] in Serum or Plasma
114
838
1.34
2.13
1.5
1.4
nmol/l
19.9
18.8
0.33
95
753
(3042936) Bacteria identified in Isolate by Culture
92
655
1.37
2.11
1.9
1.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
16
71
2.17
2.11
1.4
1.7
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
31
174
1.72
2.10
2.5
2.1
nmol/l
0.1
0.1
0.05
26
132
(3012544) pH of Venous blood
198
1569
1.25
2.09
16.1
10.0
—
7.4
—
0
8
(3026782) Osmolality of Urine
184
1446
1.26
2.09
5.0
3.3
mosm/kgh2o
567.6
605.0
1.09
154
1260
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
35
204
1.66
2.08
2.4
1.4
umol/l
5.0
5.0
0.00
35
186
(3024354) Oxygen [Partial pressure] in Venous blood
191
1511
1.25
2.05
14.6
9.8
kpa
5.2
5.2
0.14
185
1483
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
7
19
3.53
2.05
1.6
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
18
85
2.04
2.04
16.3
8.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
79
552
1.40
2.04
2.4
2.2
iu/l
7.8
6.9
0.21
58
370
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
23
119
1.86
2.03
1.9
1.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
46
289
1.54
2.02
5.9
6.8
ng/l
195.0
214.3
0.09
39
263
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
77
537
1.40
2.01
2.8
1.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
76
529
1.40
2.01
2.9
1.9
u/ml
200.8
160.7
0.38
37
247
(3027944) Amphetamines [Presence] in Urine
91
1133
0.74
1.99
1.5
1.9
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
72
498
1.41
1.97
2.2
2.1
nmol/l
8.5
8.5
0.01
62
395
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
7
20
3.35
1.95
1.6
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
197
1574
1.24
1.94
15.6
9.9
kpa
5.7
5.8
1.03
192
1538
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
78
550
1.38
1.92
1.5
1.4
pmol/l
523.0
13673909.1
0.50
68
490
(3042733) HLA Ab [Presence] in Serum
15
68
2.12
1.89
3.3
3.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
122
923
1.30
1.88
2.2
1.8
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
44
279
1.53
1.87
7.8
5.3
mmol/l
1.2
1.2
0.49
39
245
(3013115) Eosinophils [#/volume] in Blood
506
4434
1.18
1.85
10.5
9.7
e9/l
0.2
0.2
1.18
449
3786
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
56
376
1.45
1.82
3.6
2.2
u/ml
67.1
86.8
—
6
22
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
48
313
1.49
1.81
2.7
2.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
54
361
1.45
1.80
12.7
14.4
mmol/l
-0.6
-0.2
0.27
42
278
(3002582) Erythrocytes [#/volume] in Urine
273
2274
1.20
1.77
7.0
4.2
e6/l
221.6
34.9
0.47
219
1696
(3017181) Myelocytes/100 leukocytes in Blood
65
452
1.40
1.75
6.4
5.6
%
1.1
0.4
0.71
28
134
(43055514) Macroprolactin [Presence] in Serum or Plasma
11
45
2.35
1.75
1.2
1.2
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
19
98
1.86
1.72
7.2
11.3
mg/l
10.6
9.4
0.41
19
92
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
0
44
0.00
1.71
0.0
1.9
—
1.5
—
0
32
(3019069) Monocytes/100 leukocytes in Blood
479
4196
1.17
1.71
9.9
9.2
%
8.3
8.2
0.26
453
4012
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
24
134
1.72
1.70
1.0
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
317
2686
1.18
1.69
5.4
3.3
nmol/l
70.6
67.3
1.34
298
2541
(3006504) Eosinophils/100 leukocytes in Blood
475
4161
1.17
1.69
9.7
9.1
%
2.8
3.2
2.84
453
3977
(3014111) Lactate [Moles/volume] in Serum or Plasma
94
699
1.31
1.66
16.2
14.6
mmol/l
1.3
1.3
0.20
89
628
(3022096) Basophils/100 leukocytes in Blood
462
4043
1.17
1.65
9.7
9.3
%
0.6
0.6
0.42
443
3868
(3017461) Flecainide [Moles/volume] in Serum or Plasma
5
13
3.68
1.64
3.8
3.8
umol/l
0.4
0.5
—
5
13
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
106
803
1.29
1.64
7.4
7.6
umol/l
5.6
6.1
0.34
92
669
(3030467) Casts [#/volume] in Urine by Automated count
254
2117
1.19
1.63
6.5
4.1
e6/l
0.4
0.3
0.33
199
1559
(1001926) Buprenorphine [Presence] in Urine by Screen method
74
920
0.75
1.63
1.5
1.9
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
27
159
1.64
1.59
1.7
1.3
ug/g
342.9
385.0
0.48
16
73
(3028300) Cannabinoids [Presence] in Urine
97
1156
0.78
1.56
1.5
1.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
60
421
1.38
1.56
6.0
4.9
%
0.7
0.3
0.42
22
91
(3025159) Blasts/100 leukocytes in Blood
60
421
1.38
1.56
6.5
5.8
%
0.0
0.0
0.00
24
109
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
31
2.47
1.56
1.6
5.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
96
1144
0.78
1.55
1.5
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
97
1153
0.78
1.53
1.5
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
89
1069
0.77
1.53
1.5
1.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
487
4300
1.16
1.51
9.8
8.9
e9/l
0.0
0.0
0.09
422
3602
(3036481) Cortisol [Moles/volume] in Serum or Plasma
120
934
1.26
1.51
3.4
2.6
nmol/l
321.9
350.9
0.89
115
894
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
20
2.87
1.50
1.0
1.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
486
4292
1.16
1.50
9.4
8.8
%
48.0
49.3
1.29
463
4115
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.58
1.49
1.7
2.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.58
1.49
1.7
2.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.58
1.49
1.7
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.58
1.49
1.7
2.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
283
2399
1.18
1.48
7.6
4.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
40
540
0.69
1.47
1.5
1.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
494
4373
1.16
1.46
9.5
8.9
%
36.7
35.5
1.29
470
4181
(3032080) INR in Blood by Coagulation assay
168
1362
1.21
1.45
5.1
4.1
inr
1.0
1.1
1.06
50
398
(3021440) Promyelocytes/100 leukocytes in Blood
60
428
1.36
1.43
6.7
5.7
%
0.1
0.0
0.31
27
123
(3023430) Cat dander IgE Ab [Units/volume] in Serum
29
414
0.66
1.43
1.1
1.1
u/ml
5.7
10.3
0.88
16
250
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
46
315
1.41
1.40
1.4
1.4
—
—
—
0
0
(3019225) pH of Specimen
41
275
1.44
1.39
6.4
4.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
696
6332
1.17
1.38
19.6
11.6
mmol/l
4.0
3.9
3.97
675
6106
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
165
1343
1.21
1.37
5.0
3.6
e6/l
0.7
0.9
0.31
103
742
(3001604) Monocytes [#/volume] in Blood
485
4302
1.15
1.36
9.8
8.9
e9/l
0.6
0.6
2.31
419
3603
(4035726)
47
325
1.40
1.36
1.7
1.8
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
53
671
0.74
1.35
1.2
1.2
u/ml
4.9
3.9
0.11
16
227
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
48
334
1.39
1.34
2.1
1.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
29
183
1.53
1.32
2.8
1.8
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
17
93
1.76
1.32
2.6
2.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
168
1375
1.20
1.32
5.1
3.6
e6/l
2.8
3.5
0.31
108
775
(40761536) Microorganisms panel - Urine sediment
67
493
1.32
1.32
5.0
3.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
54
385
1.36
1.31
3.8
2.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
32
2.39
1.30
1.6
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
41
2.10
1.30
1.1
1.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
12
59
1.95
1.27
1.4
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
42
2.05
1.26
1.2
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
135
1510
0.83
1.24
1.7
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
26
367
0.67
1.24
1.0
1.0
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
26
163
1.53
1.23
5.7
4.6
umol/l
431.6
430.9
0.01
26
155
(3019550) Sodium [Moles/volume] in Serum or Plasma
695
6344
1.15
1.23
19.6
11.6
mmol/l
139.4
139.4
0.10
678
6146
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
18
2.66
1.22
1.0
2.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
18
2.66
1.22
1.0
2.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
497
4439
1.14
1.21
9.7
8.9
e9/l
2.5
2.3
1.28
439
3832
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
28
181
1.49
1.17
2.1
2.6
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
6
25
2.30
1.17
1.0
1.0
u/ml
19.8
38.2
—
6
25
(3013650) Neutrophils [#/volume] in Blood by Automated count
519
4656
1.13
1.17
12.2
10.5
e9/l
3.5
3.5
0.09
442
3889
(36304419) Bacteria [Presence] in Urine
251
2146
1.15
1.16
6.4
4.0
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
53
386
1.33
1.14
1.0
1.0
mu/l
9.4
8.7
0.31
48
336
(3041096) Erythrocytes [Presence] in Urine by Automated
178
1485
1.17
1.13
4.6
2.8
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
35
0.00
1.13
0.0
1.2
—
4.6
—
0
28
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
12
199
0.57
1.13
1.8
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
61
733
0.78
1.10
1.2
1.3
—
—
—
0
0
(3020891) Body temperature
22
137
1.54
1.09
10.0
7.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
7
30
2.23
1.09
1.6
1.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
73
855
0.80
1.06
1.2
1.2
—
50.1
—
0
8
(3014133) Dog dander IgE Ab [Units/volume] in Serum
35
453
0.73
1.06
1.1
1.1
u/ml
9.1
6.4
0.18
16
253
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
27
365
0.70
1.06
1.1
1.1
u/ml
1.9
0.4
0.37
13
151
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
63
750
0.79
1.06
1.2
1.2
u/ml
2.7
3.0
0.05
40
472
(3011288) Drugs identified in Urine by Screen method
67
791
0.79
1.05
1.6
2.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
9
44
1.96
1.03
18.6
12.5
nmol/l
677.1
740.7
—
9
44
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
21
2.28
1.03
1.0
1.1
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
17
101
1.62
1.03
2.5
4.1
%
5.3
3.9
—
6
39
(3048689) Calprotectin [Mass/mass] in Stool
143
1558
0.85
0.99
3.3
3.2
ug/g
71.1
108.3
2.13
111
1221
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
58
1.82
0.98
1.3
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
49
363
1.30
0.97
1.4
1.6
nmol/l
1406.6
1041.0
1.94
38
284
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
24
158
1.46
0.95
4.3
4.2
%
51.6
49.8
0.31
24
158
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
16
96
1.60
0.94
1.7
1.3
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
19
266
0.67
0.92
1.3
1.5
u/ml
20.1
10.1
0.20
13
179
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
216
1860
1.14
0.91
3.4
3.1
mg/l
2.8
2.6
0.45
195
1661
(3000012) Reticulocyte production index
6
27
2.12
0.91
3.0
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
22
297
0.70
0.88
1.6
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
387
3927
0.90
0.88
2.0
2.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
26
340
0.72
0.87
1.1
1.1
u/ml
5.0
13.9
—
5
40
(3021706) Oxygen [Partial pressure] in Arterial cord blood
40
293
1.31
0.87
1.0
1.0
kpa
3.1
3.3
0.53
34
247
(3026008) Bacteria identified in Urine by Culture
197
1693
1.14
0.86
3.7
2.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
302
2664
1.12
0.85
8.3
5.0
e6/l
46.7
59.0
0.31
223
1777
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
36
261
1.33
0.85
16.0
18.7
%
0.7
0.8
0.15
36
261
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
132
0.57
0.84
1.0
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
73
580
1.22
0.83
5.9
7.4
ng/l
1468.9
1130.1
0.28
64
476
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
43
321
1.29
0.83
2.9
2.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
6
30
1.91
0.83
1.0
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
23
155
1.42
0.83
4.1
3.8
e9/l
3.4
3.2
0.29
23
155
(3048929) Epstein Barr virus Ab [Presence] in Serum
131
1097
1.16
0.83
2.4
1.6
—
—
—
0
0
(4306422)
16
100
1.53
0.82
1.0
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
44
527
0.79
0.81
1.8
2.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
30
213
1.35
0.81
15.0
7.6
%
56.7
58.0
0.11
30
207
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
53
408
1.25
0.81
2.1
2.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
40
297
1.30
0.81
1.0
1.0
kpa
7.4
7.2
0.19
34
250
(3004959) Base excess in Arterial cord blood by calculation
40
297
1.30
0.81
1.0
1.0
mmol/l
-1.3
-2.5
—
10
69
(3006598) pH of Arterial cord blood
40
297
1.30
0.81
1.0
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
23
156
1.42
0.80
2.3
4.3
—
—
—
0
0
(3013512) EKG study
95
777
1.18
0.80
2.5
2.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
60
692
0.82
0.80
1.1
1.2
u/ml
5.1
6.9
0.53
43
503
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
23
0.00
0.79
0.0
1.6
—
52.3
—
0
23
(3020874) Milk IgE Ab [Units/volume] in Serum
22
290
0.72
0.79
1.4
1.4
u/ml
2.5
4.3
0.40
17
199
(1761868) Lipid panel - Serum or Plasma
140
1183
1.15
0.79
1.9
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
35
256
1.31
0.79
1.6
2.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
46
1.66
0.78
1.0
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
162
1384
1.14
0.78
1.7
1.5
pmol/l
102.5
98.1
0.45
72
748
(3024928) Oxygen saturation in Venous blood
30
215
1.34
0.77
18.9
18.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
22
2.17
0.76
1.0
2.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
59
677
0.82
0.76
1.1
1.2
u/ml
0.4
1.1
2.54
37
465
(3028433) Virus identified in Specimen by Culture
9
52
1.66
0.74
1.1
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
17
111
1.47
0.73
5.4
3.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
24
168
1.37
0.72
2.7
1.9
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
38
1.76
0.71
1.4
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
88
1.52
0.71
1.1
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
331
2961
1.10
0.71
7.1
4.8
estimate
0.0
0.0
0.00
62
538
(3002385) Erythrocyte distribution width [Ratio]
748
6949
1.11
0.70
19.4
14.3
%
13.2
13.1
2.14
730
6803
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
25
1.91
0.70
2.4
2.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
410
3707
1.09
0.69
4.0
3.2
ug/l
51.1
54.6
0.19
390
3517
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
13
81
1.54
0.69
1.2
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
50
576
0.82
0.68
1.4
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
23
162
1.36
0.67
2.0
1.7
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
91
0.52
0.66
1.0
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
20
258
0.73
0.65
1.2
1.4
mg/l
6.9
4.2
0.41
14
162
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
27
1.77
0.65
4.4
2.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
171
1485
1.12
0.65
6.2
3.3
estimate
0.0
0.0
0.00
59
503
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
42
1.59
0.65
2.6
2.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
331
2973
1.09
0.64
5.2
3.3
estimate
0.0
0.0
0.00
57
503
(40768441) Liver Pathology biopsy report
11
67
1.57
0.64
2.0
2.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
22
278
0.75
0.64
1.2
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
234
2399
0.91
0.63
2.1
2.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
23
164
1.34
0.63
1.3
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
77
846
0.86
0.63
1.3
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
84
914
0.86
0.61
1.7
1.6
titre
530.5
495.4
0.05
19
148
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
11
156
0.67
0.61
1.1
1.1
—
—
—
0
0
(40763527) Lymphocytes.vacuolated [Presence] in Blood by Light microscopy
0
20
0.00
0.60
0.0
1.2
—
0.0
—
0
11
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
20
141
1.36
0.60
1.6
1.9
iu/l
2.6
5.0
—
9
50
(3012516) Albumin [Mass/volume] in Urine
67
549
1.18
0.59
3.4
4.0
mg/l
129.0
237.3
0.39
56
452
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
8
50
1.53
0.59
1.4
1.2
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
8
50
1.53
0.59
1.0
1.2
—
56.5
—
0
11
(21494814) CD8 cells/100 lymphocytes in Specimen
0
22
0.00
0.58
0.0
3.4
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
22
0.00
0.58
0.0
3.4
—
13.9
—
0
22
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
26
192
1.30
0.58
2.7
2.0
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
8
51
1.50
0.58
1.0
1.2
—
82.5
—
0
11
(3009508) Creatinine [Moles/volume] in Urine
186
1635
1.10
0.57
5.8
4.5
mmol/l
8.2
8.7
0.47
175
1542
(3035320) C reactive protein [Mass/volume] in Body fluid
14
93
1.44
0.57
1.9
1.9
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
20
251
0.75
0.57
1.3
1.1
iu/ml
2.4
6.4
—
5
34
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
15
197
0.72
0.56
1.2
2.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
22
272
0.77
0.56
1.8
1.5
iu/ml
0.0
0.0
—
5
74
(3009261) Glucose [Presence] in Urine by Test strip
329
2973
1.08
0.55
5.3
3.3
estimate
0.0
0.0
0.00
64
527
(3007566) Smooth muscle Ab [Titer] in Serum
14
185
0.72
0.55
1.9
2.2
—
62.6
—
0
23
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
94
1.43
0.55
1.3
1.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
9
57
1.51
0.54
12.9
10.0
mmol/l
1.3
1.2
—
9
49
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
322
3232
0.92
0.54
1.7
1.8
u/ml
3.5
3.2
0.08
64
617
(40760892) CBC W Ordered Manual Differential panel - Blood
173
1521
1.10
0.54
7.0
4.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
30
229
1.26
0.53
1.4
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
33
255
1.24
0.53
1.3
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
888
8360
1.14
0.53
20.0
14.7
fl
86.0
86.1
0.24
871
8214
(3002523) Influenza virus A Ag [Presence] in Specimen
33
256
1.24
0.52
1.3
1.2
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
10
63
1.52
0.52
19.8
10.2
mmol/l
1.2
1.2
—
10
57
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
17
215
0.75
0.52
1.1
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
36
414
0.82
0.51
1.1
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
9
61
1.41
0.51
1.1
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
888
8363
1.13
0.51
20.0
14.7
pg
28.9
28.9
0.02
871
8219
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
9
62
1.39
0.50
2.6
2.0
ug/l
1.0
0.8
—
9
52
(40768797) Stomach Pathology biopsy report
54
442
1.17
0.50
1.7
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
888
8364
1.13
0.50
20.1
14.7
e12/l
4.7
4.6
1.74
852
7913
(4062490)
20
146
1.31
0.50
1.8
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
38
302
1.21
0.49
6.5
3.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
708
6605
1.08
0.48
10.0
8.4
u/l
26.7
25.0
0.73
685
6375
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
14
97
1.38
0.47
1.3
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
17
122
1.33
0.47
2.1
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
889
8378
1.13
0.47
20.1
14.8
e9/l
7.0
6.9
0.28
854
7937
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
45
1.49
0.47
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
45
1.49
0.47
1.0
1.0
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
18
222
0.77
0.47
1.1
1.3
u/ml
131.3
19.3
0.47
12
178
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
24
285
0.80
0.47
1.3
1.5
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
14
179
0.74
0.46
1.7
1.9
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
65
1.47
0.46
1.3
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
41
459
0.84
0.46
1.7
1.8
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
15
189
0.75
0.46
1.4
1.2
—
0.4
—
0
10
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
47
1.42
0.45
2.1
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
47
1.42
0.45
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
47
1.42
0.45
2.1
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
47
1.42
0.45
2.6
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
47
1.42
0.45
1.3
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
47
1.42
0.45
2.1
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
123
1.32
0.45
1.2
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
131
1356
0.91
0.45
1.3
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
888
8372
1.12
0.45
20.3
15.1
g/l
134.5
133.3
1.57
873
8230
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
16
115
1.33
0.45
1.2
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
48
1.39
0.44
2.6
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
64
690
0.88
0.44
1.2
1.2
u/ml
2.2
8.6
1.52
21
200
(3003694) ABO and Rh group [Type] in Blood
258
2330
1.08
0.44
1.6
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
886
8353
1.12
0.44
20.2
14.8
e9/l
276.0
271.8
0.97
852
7931
(3025018) Bordetella pertussis Ab [Titer] in Serum
21
251
0.79
0.44
1.4
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
19
230
0.78
0.44
1.7
1.7
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
17
124
1.31
0.43
1.4
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
68
728
0.88
0.43
1.2
1.2
iu/ml
10.6
25.0
1.13
14
158
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
53
1.44
0.43
1.4
1.5
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
53
1.44
0.43
1.4
1.5
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
53
1.44
0.43
1.4
1.5
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
6
88
0.65
0.42
6.7
5.8
—
88.8
—
0
10
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
88
0.65
0.42
1.2
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
64
540
1.14
0.42
4.0
4.5
mg/mmol
215.4
8.9
0.54
58
442
(3015736) pH of Urine
264
2391
1.07
0.42
4.8
3.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
31
1.54
0.42
1.8
1.9
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
17
125
1.30
0.42
1.4
1.2
%
68.6
77.9
0.41
17
125
(40760512) CD34 cells/100 cells in Bone marrow
0
14
0.00
0.41
0.0
2.0
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
1.9
—
2.1
—
0
15
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
16
0.00
0.41
0.0
4.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
67
1.43
0.41
1.3
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
32
1.49
0.41
1.2
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
34
382
0.84
0.41
1.2
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
27
310
0.83
0.40
1.0
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
28
221
1.21
0.40
4.2
3.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
142
0.74
0.40
1.4
1.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
330
0.83
0.40
1.1
1.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
18
0.00
0.39
0.0
2.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
18
0.00
0.39
0.0
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
487
4507
1.06
0.39
5.2
4.2
mm/h
6.9
7.1
0.27
455
4168
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
105
918
1.10
0.39
2.4
2.1
ng/l
12.1
51.4
2.23
51
284
(4010399)
42
346
1.16
0.39
1.5
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
22
170
1.24
0.38
2.1
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
108
0.70
0.37
1.1
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
228
2065
1.07
0.37
5.2
3.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
32
260
1.18
0.35
1.3
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
776
7295
1.07
0.34
14.4
10.2
mg/l
20.6
22.9
1.17
556
4897
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
390
3600
1.05
0.33
3.4
2.5
mmol/l
1.1
1.1
0.65
372
3411
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
16
121
1.26
0.33
1.1
1.4
u/ml
10.2
3.5
—
6
75
(3011648) Oxygen content in Venous blood
19
147
1.24
0.33
23.8
24.4
%
11.9
11.3
0.37
19
147
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
641
5995
1.06
0.33
4.1
3.7
mu/l
2.1
2.0
1.42
596
5645
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
10
70
1.37
0.33
2.6
2.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
14
104
1.29
0.33
1.0
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
101
891
1.09
0.33
3.4
2.3
u/l
9902.6
6550.3
0.37
28
233
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
49
1.36
0.31
2.6
1.4
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
7
52
1.29
0.30
1.0
1.1
ng/l
—
63.6
—
0
10
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
16
123
1.24
0.30
1.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
820
7897
0.94
0.30
4.1
3.9
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
53
1.26
0.29
2.9
2.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
54
1.24
0.29
16.7
3.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
25
278
0.85
0.29
1.8
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
67
697
0.91
0.29
1.9
2.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
61
530
1.10
0.28
1.3
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
361
3342
1.05
0.27
3.6
2.9
mmol/mol
35.5
35.7
0.13
335
3144
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
97
988
0.93
0.26
1.7
1.5
%
1.4
1.3
0.45
91
902
(3009542) Hematocrit [Volume Fraction] of Blood
800
7546
1.06
0.26
17.2
13.5
%
39.6
39.3
0.72
712
6686
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
28
233
1.15
0.25
15.4
18.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
454
4232
1.04
0.25
6.1
4.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
9
72
1.19
0.25
1.0
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
151
1371
1.06
0.24
1.6
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
42
361
1.11
0.24
1.1
1.3
miu/ml
286.7
239.8
0.34
21
161
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
6
78
0.73
0.24
1.2
1.6
umol/l
11.5
9.5
—
6
78
(3000492) Spirometry study
47
492
0.91
0.24
1.7
1.3
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
19
212
0.85
0.24
1.3
1.2
u/ml
0.9
1.0
—
7
62
(3003338) MCHC [Mass/volume]
769
7253
1.05
0.24
17.7
13.6
g/l
335.5
334.9
1.07
759
7163
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
250
2304
1.05
0.23
1.8
1.8
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
5
36
1.33
0.23
2.8
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
235
1.14
0.23
4.5
3.1
ml/min/173m2
75.2
94.9
—
10
72
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
201
0.85
0.23
1.7
1.9
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
37
1.29
0.23
1.0
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
27
227
1.14
0.22
4.2
3.2
%
9.8
9.6
0.03
27
207
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
39
1.22
0.22
1.0
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
93
1.23
0.22
1.3
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
19
210
0.86
0.22
2.4
1.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
42
364
1.10
0.21
1.2
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
113
1022
1.06
0.21
1.8
1.8
mmol/l
1.3
1.2
0.52
104
943
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
197
1810
1.05
0.21
3.8
4.9
u/l
33.4
33.6
0.04
190
1739
(3024263) Appearance of Synovial fluid
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(4133840)
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3002481) Calcium/Creatinine [Mass Ratio] in Urine
0
11
0.00
0.21
0.0
4.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
68
604
1.08
0.21
1.5
1.8
—
—
—
0
0
(4281824)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
37
319
1.11
0.21
2.0
2.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
182
1670
1.05
0.21
4.9
3.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
45
1.27
0.20
1.5
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
106
0.81
0.20
1.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
127
1156
1.05
0.20
1.5
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
20
218
0.87
0.19
2.7
4.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
49
1.17
0.19
3.0
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
50
1.14
0.19
1.0
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
18
197
0.87
0.19
1.4
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
86
1.22
0.18
3.1
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
212
1.13
0.18
1.2
1.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
424
4116
0.97
0.18
6.5
3.8
e6/l
496.9
520.7
0.01
13
50
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
53
543
0.93
0.18
2.1
2.3
u/l
22.4
28.9
2.26
48
443
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
54
552
0.93
0.18
1.2
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
65
582
1.07
0.17
1.5
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
30
315
0.90
0.17
1.2
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
14
114
1.17
0.17
1.1
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
16
175
0.87
0.17
1.6
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
8
66
1.16
0.16
1.4
1.5
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
33
288
1.10
0.16
2.2
4.0
mg/l
382.9
408.0
0.11
33
283
(3045424) Erythrocytes [Presence] in Urine
6
75
0.76
0.15
2.7
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
9
75
1.15
0.15
1.6
1.7
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
9
77
1.12
0.15
1.4
1.3
mmol/l
1.5
1.5
—
9
72
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
15
125
1.15
0.14
1.1
1.4
u/ml
10.0
3.6
—
7
62
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
91
0.84
0.14
1.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
8
91
0.84
0.14
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
91
0.84
0.14
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
91
0.84
0.14
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
91
0.84
0.14
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
24
208
1.10
0.13
1.2
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
135
1.13
0.13
2.4
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
30
264
1.09
0.13
2.3
4.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
16
171
0.89
0.12
1.6
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
16
171
0.89
0.12
1.6
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
33
292
1.08
0.12
2.5
1.9
%
31.1
32.9
0.51
26
225
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
99
1.16
0.12
1.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
81
1.18
0.12
1.4
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
165
1612
0.97
0.11
1.7
1.7
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
12
130
0.88
0.11
1.2
1.3
u/ml
10.6
6.8
0.30
12
112
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
10
82
1.16
0.11
1.1
1.0
—
9.5
—
0
7
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
389
3755
0.98
0.11
3.3
2.5
mmol/l
1.3
1.4
4.17
363
3537
(40768443) Skin Pathology biopsy report
15
159
0.90
0.10
1.1
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
15
128
1.12
0.10
2.7
2.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
33
335
0.94
0.10
1.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
38
342
1.06
0.10
1.4
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
42
1.14
0.10
1.2
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
42
1.14
0.10
1.0
1.2
nmol/l
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
109
0.87
0.10
1.0
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
31
277
1.07
0.09
2.3
4.1
e6/l
39.2
14.0
0.34
25
195
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
20
207
0.92
0.09
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
23
203
1.08
0.09
1.2
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
51
1.12
0.09
2.8
2.5
umol/l
20.4
18.1
—
6
51
(1002224) Polysomnography panel
6
52
1.10
0.09
1.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
52
1.10
0.09
16.3
3.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
393
3785
0.98
0.08
3.3
2.5
mmol/l
2.6
2.6
0.26
366
3542
(3016018) Differential panel - Cerebral spinal fluid
20
176
1.08
0.08
2.0
3.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
12
102
1.12
0.08
2.0
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
59
0.81
0.08
1.2
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
14
147
0.91
0.08
1.1
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
146
1364
1.02
0.08
3.1
2.7
u/l
57.6
55.5
0.14
140
1257
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
65
1.03
0.08
1.4
3.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
70
0.82
0.07
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
73
1.04
0.07
3.5
1.7
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
8
74
1.03
0.07
1.3
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
7
79
0.84
0.07
2.1
2.9
u/ml
7.9
42.9
—
7
69
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
80
0.83
0.07
1.0
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
9
80
1.07
0.07
1.8
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
18
159
1.08
0.07
1.3
1.2
—
44.8
—
0
5
(4268621)
9
83
1.03
0.07
2.0
2.7
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
90
0.85
0.06
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
90
0.85
0.06
1.0
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
402
3863
0.99
0.06
3.5
2.6
mmol/l
4.2
4.3
0.58
377
3668
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
100
0.86
0.06
1.6
3.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
100
0.86
0.06
1.6
3.7
—
—
—
0
0
(3002256) Pathology report gross observation
48
442
1.04
0.06
1.2
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
26
261
0.95
0.06
1.5
1.5
—
—
—
0
0
(4034850)
11
95
1.10
0.05
7.3
5.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
46
453
0.97
0.05
1.8
1.9
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
20
202
0.94
0.05
1.5
1.5
ug/l
10.3
5.8
0.42
20
186
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
23
208
1.06
0.05
1.5
1.7
nmol/l
0.2
0.2
0.35
18
173
(3001019) Free T4 and TSH panel - Serum or Plasma
19
192
0.94
0.05
1.2
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
124
0.92
0.04
1.1
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
21
190
1.05
0.04
10.9
7.2
inr
1.0
1.2
—
7
38
(3044889) 12 lead EKG panel
279
2639
1.01
0.04
2.7
2.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
63
614
0.98
0.04
1.4
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
160
1508
1.01
0.04
5.1
2.8
kg/l
1.0
1.0
0.92
31
262
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
432
4101
1.01
0.03
2.6
2.1
mmol/l
5.4
5.3
0.67
383
3763
(3007164) IgA [Mass/volume] in Serum or Plasma
316
2997
1.01
0.02
1.7
1.6
g/l
1.6
1.5
0.06
171
1584
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
567
5390
1.01
0.02
3.6
3.3
pmol/l
14.4
14.4
0.28
509
4788
(44816559) Phosphatidylethanol [Mass/volume] in Blood
20
183
1.04
0.02
1.2
1.2
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
13
117
1.06
0.02
1.2
1.3
u/ml
2.6
16.0
2.30
13
104
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
108
1020
1.01
0.01
1.1
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
347
3319
0.99
0.01
4.3
4.2
u/l
28.3
25.1
0.91
330
3185
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
37
359
0.98
0.01
6.5
3.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
17
168
0.96
0.01
1.6
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
25
244
0.98
0.00
1.2
1.7
—
450.0
—
0
6
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
90
1.06
0.00
1.1
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
10
97
0.98
0.00
1.9
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
14
131
1.02
0.00
2.3
2.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
91
1.05
0.00
1.1
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
51
486
1.00
0.00
2.6
1.9
mmol/l
2.4
2.4
0.18
44
412
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
71
676
1.00
0.00
1.4
1.3
iu/ml
250.9
146.5
0.70
21
212
(3017732) Neutrophils [#/volume] in Blood
43
408
1.00
0.00
1.9
1.8
e9/l
3.8
4.3
0.53
37
370
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
29
277
1.00
0.00
2.2
3.9
mmol/l
3.2
3.3
0.32
29
267
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
33
315
1.00
0.00
1.2
1.3
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
15
140
1.02
0.00
2.7
2.5
mmol/l
1.2
2.0
—
9
111
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
15
140
1.02
0.00
1.1
1.4
—
—
—
0
0
(4198724)
16
155
0.98
0.00
1.6
1.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
17
160
1.01
0.00
1.1
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
78
741
1.00
0.00
3.1
3.8
ng/l
2022.0
1275.5
0.33
38
393
(44813793)
16
157
0.97
0.00
1.1
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
418
3982
1.00
0.00
7.8
5.9
ml/min/173m2
114.8
114.6
0.08
264
2560
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
41
394
0.99
0.00
1.1
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
24
226
1.01
0.00
1.4
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
24
226
1.01
0.00
1.4
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
24
226
1.01
0.00
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
24
227
1.01
0.00
1.4
1.5
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
53
0.90
0.00
1.8
6.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
1116.7
—
0
6
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
20.0
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
7
69
0.97
0.00
2.1
1.3
pmol/l
45.6
40.4
—
7
64
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
66
0.87
0.00
1.0
1.1
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
1.5
—
32.0
—
0
6
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3017894) Mustard IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
53.7
—
0
5
(3041672) Baker's yeast Ab [Presence] in Serum
5
51
0.93
0.00
1.0
1.2
—
—
—
0
0
(3049233) Organic acids panel - Urine
7
66
1.01
0.00
1.3
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.0
—
21.4
—
0
8
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
57
1.00
0.00
1.2
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
8
81
0.94
0.00
1.1
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
6
64
0.89
0.00
1.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
50
0.95
0.00
4.2
2.1
u/ml
1355.4
1097.0
—
5
50
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
72
0.93
0.00
1.3
1.5
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
7.6
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
9
93
0.92
0.00
1.1
1.1
mg/l
185.0
195.2
—
9
87
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
17.8
—
0
8
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
427.8
—
0
5
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760083) Phosphate/Creatinine [Ratio] in Urine
0
7
0.00
0.00
0.0
4.6
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
87
0.99
0.00
1.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.5
—
51.8
—
0
8
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
9
88
0.97
0.00
1.1
1.2
—
—
—
0
0
(4027681)
8
85
0.90
0.00
1.5
1.2
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
8
0.00
0.00
0.0
1.1
—
37.7
—
0
8
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
57
1.00
0.00
2.2
3.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
5
52
0.92
0.00
3.2
3.0
mmol/l
3.6
3.9
—
5
45
(3024932) HLA-DR beta [Type]
8
81
0.94
0.00
1.5
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
57
0.84
0.00
1.4
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
52
0.92
0.00
1.2
1.2
iu/ml
207.2
272.2
—
5
52
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: P16_DISORD_RELATED_LENGTH_GESTATION_FETAL_GROWTH – Disorders related to length of gestation and fetal growth
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).